The Mechanisms of Neuroprotection by Topical Rho Kinase Inhibition in Experimental Mouse Glaucoma and Optic Neuropathy
Sarah E. Quillen, Elizabeth C. Kimball, Kelsey A. Ritter-Gordy, Liya Du, Zhuochen Yuan, Mary E. Pease, Salaheddine Madhoun, Thao D. Nguyen, Thomas V. Johnson, Harry A. Quigley, Ian F. Pitha · 2024
Read The Mechanisms of Neuroprotection by Topical Rho Kinase Inhibition in Experimental Mouse Glaucoma and Optic Neuropathy by Sarah E. Quillen, Elizabeth C. Kimball, Kelsey A. Ritter-Gordy, Liya Du, Zhuochen Yuan, Mary E. Pease, Salaheddine Madhoun, Thao D. Nguyen, Thomas V. Johnson, Harry A. Quigley, Ian F. Pitha (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11583991.txt.
Description
A peer-reviewed research article from Europe PMC (2024). PurposeThe purpose of this study was to delineate the neuroprotective mechanisms of topical 2% ripasudil (Rip), a Rho kinase (ROCK) inhibitor.MethodsIn 340 mice, scheduled 2% Rip or balanced salt solution (BSS) saline drops were intermittently, unilaterally delivered. Intracameral microbead glaucoma (GL) injection increased intraocular pressure (IOP) from 1 day to 6 weeks (6W), whereas other mice underwent optic nerve (ON) crush.
Catalog record
| CREATOR | Sarah E. Quillen, Elizabeth C. Kimball, Kelsey A. Ritter-Gordy, Liya Du, Zhuochen Yuan, Mary E. Pease, Salaheddine Madhoun, Thao D. Nguyen, Thomas V. Johnson, Harry A. Quigley, Ian F. Pitha |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |